OncoCyte Corporation (OCX)
NASDAQ: OCX
· Real-Time Price · USD
3.20
0.47 (17.22%)
At close: Jun 17, 2025, 3:59 PM
OncoCyte Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.03 | -0.23 | -0.72 | -2.1 | -0.67 | -0.32 | -0.99 | -0.98 | 4.40 | -0.21 | -2.29 | -3.16 | -3.22 | -1.38 | -5.9 | -12.28 | -27.19 |
PEG Ratio | -0.00 | -0.00 | -0.00 | 0.03 | 0.02 | -0.00 | 0.03 | 0.00 | -0.04 | -0.00 | -0.19 | 0.08 | 0.05 | -0.01 | -0.2 | -0.08 | 0.55 |
PS Ratio | 0.37 | 20.93 | 339.87 | 365.06 | 139.92 | 65.77 | 60.04 | 70.61 | 142.02 | -10.74 | 85.14 | 49.22 | 96.52 | 55.04 | 330.87 | 253.80 | 379.20 |
PB Ratio | 0.08 | -2.53 | 4.02 | 1.67 | 1.46 | 0.81 | 0.69 | 0.75 | 1.11 | 1.11 | 1.13 | 1.22 | 2.41 | 3.03 | 3.28 | 5.02 | 4.00 |
P/FCF Ratio | -0.13 | -5.59 | -7.32 | -6.15 | -6.39 | -4.28 | -11.32 | -4.78 | -4.36 | -3.65 | -7.09 | -8.2 | -9.26 | -26.46 | -28.7 | -59.28 | -39.88 |
P/OCF Ratio | -0.13 | -5.81 | -7.04 | -6.35 | -6.43 | -4.53 | -11.4 | -4.78 | -4.36 | -3.95 | -7.63 | -9.01 | -10.35 | -27.96 | -29.73 | -63.76 | -43.29 |
OCF/S Ratio | -2.74 | -3.6 | -48.27 | -57.48 | -21.76 | -14.53 | -5.27 | -14.76 | -32.57 | 2.72 | -11.16 | -5.46 | -9.32 | -1.97 | -11.13 | -3.98 | -8.76 |
Debt / Equity Ratio | 0.34 | -0.3 | 0.41 | 0.16 | 0.20 | 0.11 | 0.08 | 0.07 | 0.09 | 0.10 | 0.05 | 0.05 | 0.09 | 0.09 | 0.06 | 0.06 | 0.08 |
Quick Ratio | 3.70 | 1.56 | 0.50 | 1.38 | 0.78 | 1.49 | 2.09 | 2.71 | 1.61 | 1.93 | 2.83 | 3.49 | 1.76 | 2.75 | 3.56 | 2.53 | 6.25 |
Current Ratio | 3.75 | 1.62 | 0.53 | 1.38 | 0.78 | 1.49 | 2.11 | 2.74 | 1.66 | 2.11 | 2.83 | 3.49 | 1.76 | 2.77 | 3.56 | 2.53 | 6.49 |
Asset Turnover | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | -0.04 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 |
Interest Coverage | 234.45 | -1.12K | -435.97 | -579 | -385.73 | -31.24 | -55.67 | -592.43 | -565.82 | 806.75 | -658.64 | -407.71 | -329.83 | -849.52 | -272.08 | -276.9 | -167.06 |
Return on Equity | -0.65 | 2.73 | -1.39 | -0.2 | -0.54 | -0.62 | -0.17 | -0.19 | 0.06 | -1.32 | -0.12 | -0.1 | -0.19 | -0.55 | -0.14 | -0.1 | -0.04 |
Return on Assets | -0.11 | -0.96 | -0.19 | -0.06 | -0.13 | -0.21 | -0.08 | -0.1 | 0.03 | -0.45 | -0.06 | -0.05 | -0.07 | -0.22 | -0.08 | -0.06 | -0.03 |
Return on Invested Capital | -0.13 | -1.16 | -0.22 | -0.07 | -0.09 | -0.07 | -0.09 | -0.11 | -0.04 | 0.11 | -0.06 | -0.05 | -0.08 | -0.24 | -0.09 | -0.07 | -0.03 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.62 | 0.40 | 0.43 | 0.48 | -1.9 | -0.3 | 0.58 | 0.59 | 0.03 | -0.56 | -1.15 | -0.15 | -0.37 | 0.38 | -0.88 | -0.19 | 0.07 |
Net Profit Margin | -3.12 | -22.55 | -117.33 | -43.56 | -51.87 | -50.93 | -15.13 | -18 | 8.07 | 12.77 | -9.29 | -3.89 | -7.5 | -10 | -14.02 | -5.17 | -3.49 |
Pretax Profit Margin | -3.12 | -22.55 | -117.33 | -43.56 | -51.87 | -50.93 | -15.13 | -18 | 20.06 | -2.62 | -9.18 | -4.02 | -7.23 | -9.97 | -14.02 | -6.05 | -10.22 |
Operating Profit Margin | -3.18 | -22.63 | -117.52 | -44.54 | -32.88 | -15.92 | -15.18 | -17.91 | -20.96 | -2.73 | -9.07 | -4.14 | -6.95 | -9.94 | -13.83 | -6.68 | -10.11 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -3.18 | -22.15 | -117.52 | -40.35 | -49.88 | -15.07 | -10.96 | -17.01 | -19.37 | 1.33 | -5.82 | -3.15 | -9.39 | -9.61 | -12.71 | -5.4 | -9.67 |